The risk-adjusted 1-year mortality rate was not different between Medicare Advantage and traditional Medicare beneficiaries with kidney failure who initiated dialysis.
Shailender Swaminathan, PhD
Advertisement
Articles by Shailender Swaminathan, PhD
Advertisement
Latest Updated Articles
- Comparison of Mortality Between Medicare Advantage and Traditional Medicare Beneficiaries With Kidney Failure
Published: April 7th 2022 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
3
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5
